22 . June , 2018 - Friday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Atenolol

Big Image Pronouncation: (ah-TEN-oh-lahl)
Class: Beta-adrenergic blocking agent

Trade Names:
- Tablets 25 mg
- Tablets 50 mg
- Tablets 100 mg
- Injection 5 mg/10 mL

APO-Atenol (Canada)
Gen-Atenolol (Canada)
Med-Atenolol (Canada)
Novo-Atenol (Canada)
Nu-Atenol (Canada)
PMS-Atenolol (Canada)
ratio-Atenolol (Canada)
Rhoxal-atenolol (Canada)

Mechanism of Action


Blocks beta receptors, primarily affecting heart (slows rate), vascular system (decreases BP) and, to lesser extent, lungs (reduces function).




Rapid and consistent but incomplete; approximately 50% is absorbed from the GI tract. T max is 2 to 4 h.


T max is reached within 5 min.


6% to 16% bound to plasma proteins.


Little or no metabolism by the liver.



Approximately 50% is excreted unchanged in the feces. Approximately 50% is excreted in the urine within 24 h. T ½ is approximately 6 to 7 h.


More than 85% is excreted in the urine within 24 h.


1 h (oral).


2 to 4 h (oral); 5 min (IV).


24 h (oral). For both oral and IV administration, duration of action is dose related.

Special Populations

Renal Function Impairment

Elimination is closely related to glomerular filtration rate. Significant accumulation occurs when Ccr falls below 35 mL/min/1.73 m 2 .

Indications and Usage

Treatment of hypertension (used alone or in combination with other drugs), angina pectoris resulting from coronary atherosclerosis, acute MI.

Unlabeled Uses

Migraine prophylaxis, alcohol withdrawal syndrome, ventricular arrhythmias, supraventricular arrhythmias or tachycardias, esophageal varices rebleeding, anxiety.


Hypersensitivity to beta-blockers; sinus bradycardia; greater than first-degree heart block; CHF unless secondary to tachyarrhythmia treatable with beta-blockers; overt cardiac failure; cardiogenic shock.

Dosage and Administration


PO 50 to 100 mg/day.

Angina Pectoris

PO May require up to 200 mg/day.

Acute MI

IV 5 mg over 5 min; second IV follow with 5 mg dose 10 min later.


PO 50 to 100 mg/day.


Store in a tightly closed container in a cool location.

Drug Interactions

Aluminum salts, ampicillin, calcium salts

Plasma levels and pharmacologic effects may be decreased.


May add to or reverse antihypertensive effects; potentially life-threatening situations may occur, especially on withdrawal.


Pharmacologic effects of atenolol may be increased; symptomatic bradycardia may occur.

Nifedipine, verapamil

Effects of both drugs may be increased.


Some agents may impair antihypertensive effect.


May increase orthostatic hypotension.


Pharmacologic effects of atenolol may be increased.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Hypotension; bradycardia; CHF; cold extremities; second- or third-degree heart block.


Insomnia; fatigue; dizziness; depression; lethargy; drowsiness; forgetfulness; slurred speech.


Rash; hives; fever; alopecia.


Dry eyes; blurred vision; tinnitus; dry mouth; sore throat.


Nausea; vomiting; diarrhea.


Impotence; painful, difficult or frequent urination.


Agranulocytosis; thrombocytopenic purpura.


Elevated liver enzymes and bilirubin.


Bronchospasm; dyspnea; wheezing.


Weight changes; facial swelling; muscle weakness; hyperglycemia; hypoglycemia; antinuclear antibodies; hyperlipidemia.



Abrupt withdrawal

In patients with angina pectoris or CAD, may cause exacerbation of angina, occurrence of MI and ventricular arrhythmias. Monitor patients closely. Because CAD is common and unrecognized it may be prudent not to discontinue beta-blocker therapy abruptly in patients treated only for hypertension.


Category D .


Excreted in breast milk.


Safety not established.


Dosage reduction may be necessary.

Renal Function

Reduce dose.

Hepatic Function

Reduce dose.


Deaths have occurred; aggressive therapy may be required.


Administer cautiously in patients with CHF controlled by digitalis and diuretics.

Diabetes mellitus

May mask symptoms of hypoglycemia (eg, tachycardia, BP changes).

Nonallergic bronchospastic diseases (eg, chronic bronchitis, emphysema)

In general, do not give beta-blockers to patients with bronchospastic diseases.

Peripheral vascular disease

May precipitate or aggravate symptoms of arterial insufficiency.


May mask clinical signs (eg, tachycardia) of developing or continuing hyperthyroidism. Abrupt withdrawal may exacerbate symptoms of hyperthyroidism, including thyroid storm.



Bradycardia, hypotension, CHF, cardiogenic shock, hypertension, cardiac arrhythmias, seizures, respiratory depression, coma, pulmonary edema, bronchospasm, hypoglycemia.

Patient Information

  • Explain that full effectiveness of drug may not occur for up to 1 to 2 wk after initiation of therapy, and that dosage will be tapered slowly before stopping. Warn that sudden discontinuation can cause chest pain or heart attack.
  • Teach patient how to take pulse and instruct patient to check before taking drug. Warn patient not to take drug if pulse is less than 60 bpm, and to call health care provider.
  • When medication is being used for treatment of hypertension, teach patient how to take daily BP.
  • Advise patient that medication may cause increased sensitivity to cold.
  • Inform patients with diabetes to monitor blood glucose level carefully. It may be necessary to alter insulin dose while taking drug.
  • Instruct patient to report the following symptoms to health care provider: difficulty breathing; swelling of feet, legs, and hands; irregular heart beat; altered mood; depression.
  • Caution patient to avoid sudden position changes to prevent orthostatic hypotension.
  • Advise patient that drug may cause drowsiness, and to use caution while driving or performing other tasks requiring mental alertness.

Recent Drug Updates at DrugIndexOnline:

Afeditab CR Afeditab CR
Generic Name: nifedipine Dosage Form: Extended-release tablets Afeditab CR Description Afeditab® CR is an extended release tablet dosage form of the calcium channel blocker nifedipine. Nifedipine is 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-dimethyl ester, C17H more...

Americaine Otic Drops Americaine Otic Drops
Generic Name: Benzocaine Ear Drops (BEN-zoe-kane) Brand Name: Examples include Americaine Otic and OtocainAmericaine Otic Drops is used for:Relieving pain and itching in the ear caused by ear infections. It may also be used for other conditions as determined by your doctor. Americaine Otic Drop more...

Antivenin, Sea Snake Antivenin, Sea Snake
Some commonly used names are antivenin (Enhydrina schistosa ) and sea snake antivenom . *† Not commercially available in the U.S. and Canada. Category Immunizing agent, passive Description Sea snake antivenin belongs to a group of medicines known as antivenins. It is used for the more...

Apokyn Apokyn
Generic Name: Apomorphine (a-poe-MOR-feen) Brand Name: ApokynApokyn is used for:Treating loss of control of body movements such as muscle stiffness, slow movements, or trouble moving associated with advanced Parkinson disease. Apokyn is a dopamine agonist. It works by stimulating dopamine rece more...

Chlordiazepoxide Chlordiazepoxide
Generic Name: Chlordiazepoxide hydrochloride Dosage Form: Capsules usp civ Chlordiazepoxide Description Chlordiazepoxide hydrochloride is the prototype for the benzodiazepine compounds. Chlordiazepoxide hydrochloride is 7-chloro-2-(methylamino)-5-phenyl-3 H-1,4-benzodiazepine 4-oxide hydrochlorid more...

Cortastat Cortastat
Some commonly used brand names are: In the U.S.— Acetocot 9 A-hydroCort 5 Amcort 9 A-MethaPred 6 Aristocort 9 Aristocort Forte 9 Aristopak 9 Aristospan 9 Articulose-50 7 Articulose-L.A. 9 Celestone 1 Celestone Phosphate 1 Celestone Soluspan 1 Cinalone 40 9 Cinonide 40 9 Clinacort 9 Clinal more...

Halotussin Halotussin
Some commonly used brand names are: In the U.S.— Anti-Tuss Breonesin Diabetic Tussin EX Fenesin Gee-Gee Genatuss Glycotuss Glytuss Guiatuss Halotussin Humibid L.A. Humibid Sprinkle Hytuss Hytuss-2X Naldecon Senior EX Organidin NR Pneumomist Robitussin Scot-tussin Expectorant Sinumist-SR T more...

Podofilox Topical Podofilox Topical
Some commonly used brand names are: In the U.S.— Condylox Another commonly used name is podophyllotoxin . Category Antimitotic agent (topical) Description Podofilox (po-do-FIL-ox) is used to remove certain types of warts on the outside skin of the genital areas (penis or vulva). more...